Catalyst Pharma Q4 and FY14 results

• Catalyst Pharmaceuticals (NASDAQ:CPRX +0.2%) Q4 results: Revenues: $0; R&D Expense: $2.4M (+14.3%); SG&A: $1.6M (+166.7%); Net Loss: ($3.5M) (-150.0%); Loss Per Share: ($0.05) (-66.7%).
• FY2014 results: Revenues: $0; R&D Expense: $10.1M (+24.7%); SG&A: $4.5M (+104.5%); Operating Loss: ($14.6M) (-41.7%); Net Loss: ($15.5M) (-27.0%); Loss Per Share: ($0.24) (+11.1%); Quick Assets: $35.6M (+80.7%).
• No guidance given.